Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer

As one of the most commonly used chemotherapeutic drug for papillary thyroid cancer (PTC), euthyrox affects the therapeutic outcome due to the resistance of euthyrox. Hsa_circ_0002111 is highly expressed in euthyrox-resistant PTC patients, and this study intends to explore its role in euthyrox drug...

Full description

Bibliographic Details
Main Authors: Jing Zhou, Jing Liu, Weiyuan Ma, Pengxin Zhao
Format: Article
Language:English
Published: Innovation Publishing House Pte. Ltd. 2022-04-01
Series:STEMedicine
Subjects:
Online Access:https://stemedicine.org/index.php/stem/article/view/127
_version_ 1811311459701882880
author Jing Zhou
Jing Liu
Weiyuan Ma
Pengxin Zhao
author_facet Jing Zhou
Jing Liu
Weiyuan Ma
Pengxin Zhao
author_sort Jing Zhou
collection DOAJ
description As one of the most commonly used chemotherapeutic drug for papillary thyroid cancer (PTC), euthyrox affects the therapeutic outcome due to the resistance of euthyrox. Hsa_circ_0002111 is highly expressed in euthyrox-resistant PTC patients, and this study intends to explore its role in euthyrox drug resistance. PTC patient samples were used to screen for Circ_0002111 expression. TPC-1 and K1 PTC cell lines and their corresponding euthyrox-resistant cell lines (TPC-1/euthyrox and K1/euthyrox), and a benign human thyroid follicular cell line (Nthy-ori 3-1) were used in in vitro experiments. Circ_0002111 was knocked down in euthyrox-resistant cell lines, and cell viability and colony formation were detected. Caspase-3 activity assay and nucleosomal fragmentation assay were used for the detection of apoptosis. Luciferase reporter assay and biotin-labeled RNA pulldown assay were used to analyze interactions between Circ_0002111 and miR-557, or miR-557 and DUSP14. The upregulation of Circ_0002111 was found in PTC patient samples and associated with euthyrox-resistance in poor prognosis of PTC patients. Experiments in cell lines showed that Circ_0002111 regulates euthyrox-resistance in PTC cells. Mechanistic studies showed that Circ_0002111 promoted DUSP14 expression through miR-557, and euthyrox-resistance in PTC cells depended on the regulation via miR-557/DUSP14 signaling pathways. In conclusion, Hsa_circ_0002111 promotes euthyrox-resistance of PTC cells by adsorption miR-557 upregulation, suggesting Circ_0002111 might be a potential diagnostic marker and therapeutic target for euthyrox-resistant PTC patients.
first_indexed 2024-04-13T10:18:08Z
format Article
id doaj.art-0df4a530cdf1471b865dc36647f1a7e4
institution Directory Open Access Journal
issn 2705-1188
language English
last_indexed 2024-04-13T10:18:08Z
publishDate 2022-04-01
publisher Innovation Publishing House Pte. Ltd.
record_format Article
series STEMedicine
spelling doaj.art-0df4a530cdf1471b865dc36647f1a7e42022-12-22T02:50:35ZengInnovation Publishing House Pte. Ltd.STEMedicine2705-11882022-04-013210.37175/stemedicine.v3i2.127Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancerJing Zhou0Jing Liu1Weiyuan Ma2Pengxin Zhao3The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaThe Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaThe Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, ChinaThe Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China As one of the most commonly used chemotherapeutic drug for papillary thyroid cancer (PTC), euthyrox affects the therapeutic outcome due to the resistance of euthyrox. Hsa_circ_0002111 is highly expressed in euthyrox-resistant PTC patients, and this study intends to explore its role in euthyrox drug resistance. PTC patient samples were used to screen for Circ_0002111 expression. TPC-1 and K1 PTC cell lines and their corresponding euthyrox-resistant cell lines (TPC-1/euthyrox and K1/euthyrox), and a benign human thyroid follicular cell line (Nthy-ori 3-1) were used in in vitro experiments. Circ_0002111 was knocked down in euthyrox-resistant cell lines, and cell viability and colony formation were detected. Caspase-3 activity assay and nucleosomal fragmentation assay were used for the detection of apoptosis. Luciferase reporter assay and biotin-labeled RNA pulldown assay were used to analyze interactions between Circ_0002111 and miR-557, or miR-557 and DUSP14. The upregulation of Circ_0002111 was found in PTC patient samples and associated with euthyrox-resistance in poor prognosis of PTC patients. Experiments in cell lines showed that Circ_0002111 regulates euthyrox-resistance in PTC cells. Mechanistic studies showed that Circ_0002111 promoted DUSP14 expression through miR-557, and euthyrox-resistance in PTC cells depended on the regulation via miR-557/DUSP14 signaling pathways. In conclusion, Hsa_circ_0002111 promotes euthyrox-resistance of PTC cells by adsorption miR-557 upregulation, suggesting Circ_0002111 might be a potential diagnostic marker and therapeutic target for euthyrox-resistant PTC patients. https://stemedicine.org/index.php/stem/article/view/127miR-557Circ_0002111Euthyrox resistantDUSP14Umael
spellingShingle Jing Zhou
Jing Liu
Weiyuan Ma
Pengxin Zhao
Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer
STEMedicine
miR-557
Circ_0002111
Euthyrox resistant
DUSP14
Umael
title Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer
title_full Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer
title_fullStr Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer
title_full_unstemmed Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer
title_short Hsa_circ_0002111/miR-557/DUSP14 axis mediates euthyrox-resistance in papillary thyroid cancer
title_sort hsa circ 0002111 mir 557 dusp14 axis mediates euthyrox resistance in papillary thyroid cancer
topic miR-557
Circ_0002111
Euthyrox resistant
DUSP14
Umael
url https://stemedicine.org/index.php/stem/article/view/127
work_keys_str_mv AT jingzhou hsacirc0002111mir557dusp14axismediateseuthyroxresistanceinpapillarythyroidcancer
AT jingliu hsacirc0002111mir557dusp14axismediateseuthyroxresistanceinpapillarythyroidcancer
AT weiyuanma hsacirc0002111mir557dusp14axismediateseuthyroxresistanceinpapillarythyroidcancer
AT pengxinzhao hsacirc0002111mir557dusp14axismediateseuthyroxresistanceinpapillarythyroidcancer